Stacey Seggelke, CNS, MS, RN

Professional Titles

• Asstant Professor
• Professional Development Coordinator for the Office of Advanced Practice

Recognitions

• Expert Council for Clinical Excellence and Leadership, University of Colorado School of Medicine (2018)
• Full-Time Allied Health Provider of the Year Award, University of Colorado Hospital Medical Staff (2013)

Publications

• Hirsch IB, Draznin B, Buse JB, et al. Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study. Diabetes Care. 2025;48(1):118-124. doi:10.2337/dc24-1779
• Low Wang CC, Seggelke SA, McDermott MT, Reusch JEB. Chapter 2: Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance. In Meyers AK. Diabetes and COVID-19: Considerations and Clinical Management. Springer Publishing Company 2023
• Griff M, Crawley S, Rowland A, Seggelke S, Hawkins RM, Grafals M, Low Wang CC. Diabetes management at the time of renal transplantation. American Diabetes Association’s 82nd Scientific Sessions 2022. New Orleans, Louisiana. Poster 1293-P. Category 19: Transplantation.
• Seggelke SA, Griff M, Crawley S, Rowland A, Hawkins RM, Low Wang CC. Dysglycemia in patients without diabetes after renal transplantation. American Diabetes Association’s 82nd Scientific Sessions 2022. New Orleans, Louisiana. Poster 928-P. Category 13-B Health Care Delivery—Quality Improvement.
• Seggelke SA, Ingram CC, Crawley S, Low Wang CC. Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review. Clinical Diabetes. 2021.
• Seggelke S and Hawkins, RM. Inpatient management of diabetes and hyperglycemia. In: McDermott MT (Ed). Endocrine Secrets, 7th Edition. St. Louis, MO, Elsevier, 61 – 66.
• 5. Seggelke S: Contributing Reviewer – Patient Sel-Management Education and Support. In Medical Management of Type 1 Diabetes, 7th edition. Low Wang CC, Shah A, Eds. Alexandria, VA, American Diabetes Association, 2017, p. 45 – 58.
• Seggelke SA, Lindsay MC, Hazlett I, Sanagorski R, Eckel R, Low Wang CC. Cardiovascular safety of antidiabetic drugs in the hospital setting. Current Diabetes Reports, 2017; 17(8):64
• Wang YJ, Seggelke S, Hawkins RM, Gibbs J, Lindsay M, Hazlett I, Low Wang CC, Rasouli N, Young KA, Draznin B. IMPACT OF GLUCOSE MANAGEMENT TEAM ON OUTCOMES OF HOSPITALIZARON IN PATIENTS WITH TYPE 2 DIABETES ADMITTED TO THE MEDICAL SERVICE. Endocr Pract. 2016 Dec;22(12):1401-1405. PubMed PMID: 27540884
• Seggelke S: Contributing Reviewer – Inpatient Diabetes Education. In Medical Management of Type 1 Diabetes, 7th edition. Low Wang CC, Shah A, Eds. Alexandria, VA, American Diabetes Association, (in press).
• Draznin B., Dungan K., Seggelke S. Insulin resistance in patients treated with therapeutic hypothermia and in patients with severe burns. In Managing Diabetes and Hyperglycemia in the Hospital Setting: A Clinician’s Guide. Alexandria, VA, American Diabetes Association, 201, p. 192-197.
• Seggelke S, Draznin B. Therapeutic Hypothermia and Severe Insulin Resistance in Patients with Diabetes and Cardiac Arrest. In Diabetes Case Studies. Draznin B, Low Wang CC, Rubin DJ, Eds. Alexandria, VA, American Diabetes Association, 2015, p. 211-213.
• Seggelke SA. Factitious Hypoglycemia in a Type 2 Diabetic Patient. In Diabetes Case Studies. Draznin B, Low Wang CC, Rubin DJ, Eds. Alexandria, VA, American Diabetes Association, 2015, p. 314-316.
• Draznin D, Wang Y, Seggelke S, et al. Glycemic control and outcomes of hospitalization in noncritically ill patients with Type 2 diabetes admitted with cardiac problems or infections. Endocrine Practice. 2015(12): 1303 – 1308.
• Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995). 2014 Feb;42(1):46-51. PubMed PMID: 24566596
• Draznin B, Wang Y, Seggelke S, Hawkins RM, Gibbs J, Bridenstine M, Rasouli N, Wang CL. Glycemic control and outcomes of hospitalization in noncritically ill patients with type 2 diabetes admitted with cardiac problems or infections. Endocr Pract. 2014 Dec 1;20(12):1303-8. PubMed PMID: 25100383
• Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang CC, Draznin B. Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes. Endocr Pract. 2014 Jun;20(6):536-9. PubMed PMID: 24326004
• Seggelke SA, Hawkins M, Gibbs J, Rasouli N, Wang C, and Draznin B. Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: A pilot quality improvement study. Hospital Practice. 2014; 42(1): 46 – 51.
• Seggelke S. Hypoglycemia: Fear of the low. American Nurse Today. 2014; 9 (8).
• Seggelke S. Supplemental nutrition in hospitalized patients with diabetes. American Nurse Today. 2014; 9 (12)
• Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Low CC, Draznin B. Effect of Glargine Insulin Delivery Method (Pen-Device vs. Vial-Syringe) on Glycemic Control and Patient Preferences in Patients with Type 1 and Type 2 Diabetes. Endocr Pract. 2013 Dec 10;:1-12. [Epub ahead of print] PubMed PMID: 24326004
• Seggelke S, Everhart B. Management of type 2 diabetes. Nurse Pract. 2013 Jun 10;38(6):13-6. PubMed PMID: 23695708
• Seggelke SA. Severe hypoglycemia leads to a seizure. American Nurse Today. 2013; 8(7): 11
• Chapter on Inpatient Diabetes Management
• Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions. Rasouli N, Seggelke S, Gibbs J, Hawkins RM, Casciano ML, Cohlmia E, Taylor-Cousar J, Wang C, Pereira R, Hsia E, Draznin B. J Diabetes Sci Technol. 2012 Sep 1;6(5):1038-44.
• Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, Wang C, Kam I, Draznin B. J Clin Endocrinol Metab. 2012 Sep;97(9):3132-7. doi: 10.1210/jc.2012-1244. Epub 2012 Jun
• Seggelke S and Everhart B. Managing glucose levels in hospitalized patients. American Nurse Today. 2012 Sep; 7(9):27-31
• Seggelke SA. Hitting the target for inpatient glycemic management. Nurse Practitioner. 2011; 36(5): 24–31.
• Seggelke, SA. (2011). Hitting the target for inpatient diabetes management. Nurse Practitioner. 36(5): 24 – 31.
• Seggelke, SA, Gibbs, J, Draznin, B. (2011). Neutral protamin hagedorn insulin to conteractth effect of methylprednisone in hospitalized patients with diabetes. Journal of Hospital Medicine. 6(3): 175-176.
• Hsa, E, Seggelke, SA, Gibbs, J, Rausoli, N, Draznin, B. (2011). Comparision of 70/30 biphasic insulin with glargine/lsipro in non-critically ill diabetic patietns on continuous eneteral therapy. Nutrition in Clnical Practice 26(6); 714-717.
• Seggelke S: Contributing Reviewer – Inpatient Diabetes Education. In Medical Management of Type 1 Diabetes, 7th edition. Low Wang CC, Shah A, Eds. Alexandria, VA, American Diabetes Association, (in press).
• Seggelke, S. Endocrine Pharmacology: Glycemic Management, Hypothyroidism. In Adult-Gerontology Clinical Nurse Specialist Examination Review Book – In Process
• Seggelke, S. Endocrine Pathophysiology In Adult-Gerontology Clinical Nurse Specialist Examination Review Book – In Process

Professional Memberships

• American Diabetes Association, Professional Member
• National Association of Clinical Nurse Specialists, Professional Member

Practice Locations

UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

UCHealth Diabetes and Endocrinology Clinic - Anschutz Medical Campus
1635 Aurora Ct
6th Floor
Aurora, CO 80045
720-848-2650

Hospital Affiliation

• University of Colorado Hospital

Specialty Information

Specialties

• Clinical Nurse Specialist, Certificate (0001)
• Doctorate of Nursing Practice, Focused Practice Designation (2018)

Conditions & Treatments

• Endocrine System (Hormones)